Presurance Holdings reported a net loss of $1.6 million in Q3 2026 but showed significant improvement in underwriting performance, with the combined ratio dropping to 113.2% from 141.2% a year earlier. The company's personal lines business, focused on Texas homeowners, delivered profitable results with a combined ratio of 82.7% in Q3. Gross written premiums declined due to selective underwriting and exiting less profitable markets, while legacy commercial lines remain in runoff with reserve strengthening impacting results. Management highlighted ongoing progress in core operations and disciplined risk management as key to future profitability.
Presurance Holdings' Q3 2026 results show a combined ratio improvement to 113.2% from 141.2% a year earlier, signaling better underwriting performance despite a net loss of $1.6 million. For readers following the Financials sector, here is Pluang's market snapshot as of Nov 12, 2026 19:21 WIB: among 142 priced US Financials stocks, 67 rose and 60 fell. Notable movers include CLSK at USD 6.59 with 71% sell orders, BTBT at USD 0.76 with 83% buy orders, and WULF at USD 12.76 with 73% sell orders.
Interlink Electronics announced a 3.4% revenue increase to $3.06 million for Q3 2026 and a 9.6% rise to $9.9 million for the first nine months of 2026, driven by higher shipments of force-sensing and gas-sensor products. The company reported a net lo...
ALS Canada, with renewed funding from TD Bank, is advancing its national strategy for ALS genetics to enhance access to genetic information, counselling, and care for Canadians affected by or at risk of ALS. This builds on the 2024 pilot of the first...
The Canadian ALS Society has renewed funding from TD Bank to expand its national genetics strategy for ALS, improving access to genetic information, counseling, and care for those affected or at risk. This initiative builds on a pilot project that cr...
CollPlant Biotechnologies will change its Nasdaq ticker from CLGN to OPHI starting November 13, 2026, reflecting its strategic shift toward photonic computing through its subsidiary LightSolver. This move highlights CollPlant's focus on developing Li...
Evaxion, a clinical-stage TechBio company, has released its financial calendar for 2027, outlining important dates for business updates and financial results. Key events include the full year 2026 results on March 4, the Annual General Meeting on Apr...
